Non-arteritic anterior ischemic optic neuropathy (NAION) is the most common cause of acute optic neuropathy in people aged 50 and above. The precise mechanism of NAION remains unclear and no consistently effective treatment, either medical or surgical method, for NAION has been identified. Thus, further study of the pathogenesis, higher research level of the treatment trail and the effective neuroprotective approaches are of significant importance for the treatment of NAION. (Chin J Ophthalmol, 2019, 55: 164-168).
非动脉炎性前部缺血性视神经病变(NAION)是50岁以上人群最常见的急性视神经病变。由于NAION的发病机制尚不明确,因此目前NAION的治疗方法多种多样,并未形成共识。本文从NAION发病机制、NAION治疗研究证据级别以及NAION的神经保护研究方面,分析目前NAION的各种治疗策略及存在的问题,以期为客观评估NAION的治疗方法及其疗效、深入研究NAION的有效治疗途径提供参考。(中华眼科杂志,2019,55:164-168).
Keywords: Clinical protocols; Optic neuropathy, ischemic.